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a b s t r a c t
The Tax protein expressed by human T-cell leukemia virus type 1 (HTLV-1) plays a pivotal role in the
deregulation of cellular pathways involved in the immune response, inﬂammation, cell survival, and
cancer. Many of these effects derive from Tax multiple interactions with host factors, including the
subunits of the IKK-complex that are required for NF-κB activation. IKKɛ and TBK1 are two IKK-related
kinases that allow the phosphorylation of interferon regulatory factors that trigger IFN type I gene
expression. We observed that IKKɛ and TBK1 recruit Tax into cellular immunocomplexes. We also found
that TRAF3, which regulates cell receptor signaling effectors, forms complexes with Tax. Transactivation
analyses revealed that expression of Tax, in presence of IKKɛ and TBK1, enhances IFN-β promoter activity,
whereas the activation of NF-κB promoter is not modiﬁed. We propose that Tax may be recruited into
the TBK1/IKKɛ complexes as a scaffolding-adaptor protein that enhances IFN-I gene expression.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Human T-cell lymphotroﬁc virus type 1 (HTLV-1) is the causa-
tive agent of two severe diseases, the adult T-cell leukemia/
lymphoma (ATLL) and the neurodegenerative disorder HTLV-1
associated myelopathy/tropical spastic paraparesis (HAM/TSP)
(Gessain and Mahieux, 2012; Yamagishi and Watanabe, 2012).
An estimated 2 to 5% of the 5 to 10 million HTLV-1 infected people
worldwide develop HTLV-1 diseases (Gessain and Cassar, 2012). In
the last thirty years, the identiﬁcation of both HTLV-1 proteins and
cellular factors that may be involved in the complex and multi-
step mechanism of cell transformation and leukemia development
has been widely investigated (Matsuoka and Jeang, 2007; Barbeau
et al., 2013; Cavallari et al., 2013; Forlani et al., 2013; Ren and
Cheng, 2013). To attribute speciﬁc roles to the factors acting in the
transforming process, several studies revealed differences
between HTLV-1 and HTLV-2 (as reviewed by Ciminale et al.,
2014; Rende et al., 2012; Barbeau et al., 2013; Cavallari et al., 2013;
Forlani et al., 2013; Pilotti et al., 2013; Romanelli et al., 2013;
Shirinian et al., 2013). Although HTLV-2 has not been associated
with lymphoma and leukemia, it sporadically causes mild lym-
phocytosis and neurologic disorders (Araujo and Hall, 2004;
Roucoux and Murphy, 2004; Biswas et al., 2010). Both viruses
share a high genomic similarity and contain an X region coding for
Tax proteins Tax-1 and Tax-2. Tax-1 is involved in the induction of
oncogenic signaling activation and T-cells transformation in vitro
(Azran et al., 2004; Matsuoka and Jeang, 2007; Kannian and Green,
2010; Ohsugi, 2013). Tax-2 also induces transformation in vitro
that immortalizes CD4þ T-cells (Imai et al., 2013). Tax-1 expres-
sion is critical for both viral and cellular functions. In the initial
steps of the viral infection, Tax-1 plays an essential role in the
proviral gene expression by activating viral gene transcription
from the 50 long terminal repeat (LTR) promoter (Currer et al.,
2012). Tax-1 also interacts with many key cellular factors of cell
signaling pathways, resulting in gene expression deregulation, cell
cycle progression, inhibition of apoptosis, and interference with
DNA repair (Bertazzoni et al., 2011; Currer et al., 2012). Tax
proteins localize in both the nucleus and the cytoplasm, resulting
in display of a peculiar punctuated distribution that originates
from accumulation of multi-factor complexes known as nuclear
bodies (Bex et al., 1997; Turci et al., 2009; Bertazzoni et al., 2011).
Tax proteins constitutively activate NF-κB by interacting with
several factors involved in the NF-κB pathway. In the cytoplasm,
Tax interacts both with the regulatory subunit IKKγ/NEMO and the
catalytic subunits IKKα and IKKβ, allowing IκB degradation and
nuclear translocation of RelA (Chu et al., 1998; Harhaj and Sun,
1999). Furthermore, Tax-1 interacts and colocalizes with upstream
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kinase complexes consisting of TAK1 and the adaptor protein TAB2
(Chu et al., 1998; Avesani et al., 2010). Ubiquitination and sumoy-
lation of both Tax-1 and Tax-2 play critical roles in NF-κB
activation (Turci et al., 2012). By binding to the canonical IκB
kinase (IKK)-complexes, including the essential modulator IKKγ/
NEMO, IKKα and IKKβ, Tax-1 induces the binding of upstream
activated kinases, MEKK1 and TAB2, to the IKK-complexes (Yin
et al., 1998; Harhaj and Sun, 1999; Jin et al., 1999; Wu and Sun, 2007).
Several kinases facilitate crosstalk between signaling pathways,
thus emerging as cellular targets for modulating cellular response
in pathogenic conditions. Two closely related serine-threonine
kinases, the TANK binding kinase-1 (TBK1) and the inducible I-κB
kinase epsilon (IKKɛ), are directly involved in the innate immune
response to viral infection and inﬂammatory stimuli by inducing
type I interferon (IFN-I) and modulating NF-κB signaling
(reviewed by Häcker and Karin, 2006; Chen and Jiang, 2013).
The IKKɛ/TBK1 kinase complex is involved in the direct phosphor-
ylation of the transcription factors IFN regulatory factors 3 and 7
(IRF3 and IRF7), allowing the activation of IFN-β gene (Fitzgerald et
al., 2003; Sharma et al., 2003). The phosphotransferase activities of
TBK1 and IKKε are regulated by scaffolding effectors, including
TANK, NAK associated protein 1 (NAP1), similar NAP and TBK1
adaptor (SINTBAD) and TNF-receptor associated factor 3 (TRAF3)
(Goncalves et al., 2011; Verhelst et al., 2013). In addition to their role
in innate immunity, TBK1 and IKKɛ are directly involved in tumor
cell survival (Clément et al., 2008; Barbie et al., 2009; Li et al., 2014).
Activation of TBK1 and IKKε in response to pathogen infection is
essential for the instauration of an antiviral response (Fitzgerald
et al., 2003; Sharma et al., 2003; Clément et al., 2008; Helgason et
al., 2013). Viruses have evolved numerous mechanisms for blocking
TBK1/IKKε phosphorylation of IRF factors (Randall and Goodbourn,
2008; Zhao, 2013) that impact pattern recognition receptor signal-
ing pathways (Bowie and Unterholzner, 2008). Such receptor signal-
ing pathways include the C6 protein of Vaccinia virus (Unterholzner
et al., 2011), the largest tegument protein of herpes simplex virus 1
(HSV-1) (Wang et al., 2013), the ORF11 of murine gamma herpes-
virus 68 (Kang et al., 2014), the Borna disease virus P protein
(Unterstab et al., 2005) and the paramyxovirus V proteins (Lu et al.,
2008). However, the mechanism by which HTLV-1 escapes from the
antiviral response remains to be clariﬁed (Kinpara et al., 2009;
Sugata et al., 2012).
This study explores the interactions between Tax proteins and
the IKK-related kinases that impact on cellular behavior with a
focus on how the interactions result in avoidance of the immune
response.
Material and methods
Cell culture and transfection
HEK 293T cells were maintained in Dulbecco’s modiﬁed Eagle’s
Medium (DMEM) supplemented with 10% fetal calf serum (FCS),
L-glutamine (2 mM), Penicillin G(100 U/L)/Streptomycin (100
mcg/L). Jurkat T cells were grown to a density of 3105 cells/mL
in 1640 RPMI medium supplemented with 10% FCS, L-glutamine
(2 mM) and Penicillin G (100 U/L)/Streptomycin (100 mcg/L). For
immunoprecipitation 6105 293T cells were plated in 35 mm
dishes. For transactivation studies 1.25105 293T cells were
seeded in 12-well plates. After 24 h, cells were transfected using
TransIT-L™T1 transfection reagent (MIR2300, Mirus Bio) following
the manufacturer’s protocol. For transactivation analysis of Jurkat
cells, 1.5106 cells were pelleted and transfected using Amaxa™
Cell Line Nucleofector™ Kit V (Lonza) following manufacturer’s
instructions.
Antibodies and plasmids
Anti-Flag antibodies (OctA-probe sc-807 rabbit polyclonal and
OctA-probe sc-51590 monoclonal), anti-GFP rabbit polyclonal
antibody conjugated with HRP (sc-8334), and anti-β-tubulin
(H-235) rabbit polyclonal antibody (sc-9104) were purchased from
Santa Cruz Biotechnology; anti-V5 antibody (R96025) was
obtained from Invitrogen. The anti-Tax-1 monoclonal antibody
derives from hybridoma 168-A51 (AIDS research and Reagent
Program, National Institutes of Health). The anti-Tax-2 rabbit poly-
clonal speciﬁc antibody was obtained as previously described
(Turci et al., 2012). Goat anti-rabbit horse radish peroxidase
(HRP)-conjugated (Sigma-Aldrich) and goat anti-mouse HRP-con-
jugated (Thermo scientiﬁc) were secondary antibodies. The
expression vectors for Tax-1 and Tax-2B full length and Tax-1
truncated mutants were previously described (Lamsoul et al.,
2005; Tosi et al., 2011; Turci et al., 2009, 2012). The pcDNA3-
Flag-IKKε, pcDNA3-Flag-IKKεΔC, pCDNA3-Flag-TBK1, pEGFP-C1-
DDX3, p55C1B-Luc, pIRF3-GFP, pcDNA3-TBK1-Myc, pcDNA3-
TRAF3-Flag, HA-TRAF3 plasmids were kindly provided by Schmitz
(Mattioli et al., 2006), Lin (Breiman et al., 2005), Kracht (Buss et al.,
2004), Tarn (Lai et al., 2008), Fujita (Yoneyama et al., 1996), Hiscott
(Lin et al., 1998), Chariot (Gatot et al., 2007), Servant (van Zuylen et
al., 2012) and Harhaj (Charoenthongtrakul et al., 2013),
respectively.
Immunoprecipitation and Western blot
Whole cell extracts were prepared from HEK 293T cells
transfected with speciﬁc expressing vectors. Twenty four hours
after the transfection reaction, cells were harvested, washed twice
in ice cold PBS 1X, resuspended in 120 μL of non-denaturing lysis
buffer (10 mM Tris–HCl, pH 7.5, 5 mM EDTA, 150 mM NaCl, 1%
Triton X-100) with the addition of protease inhibitors (P8340,
Sigma) and incubated for 10 min on ice. Lysates were sonicated
twice for 5 s and frozen at 20 1C for 1 h. Cellular debris was
removed by centrifugation. The immunoprecipitation was per-
formed using antibodies against Flag, Tax-1 or Tax-2 and Dyna-
beadss Protein G or A (Life Technologies). Brieﬂy, lysates were
incubated overnight at 4 1C with the speciﬁc antibody, and the
immunocomplexes were linked to magnetic beads of either
Protein G or A at 4 1C for 30 min. Beads were washed three times
with PBS and ﬁnally resuspended in elution buffer containing
NuPAGE loading buffer (Life Technologies) and DTT 0.25 mM.
Samples were resolved in SDS polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred to a PVDF membrane (GE Healthcare).
The membranes were Western blotted with selected antibodies,
and the bound antibodies were visualized with appropriate HRP-
linked secondary antibodies using ECL Western blotting Substrate
(Promega) according to manufacturer’s instructions.
Reporter gene assay
At 24 h after seeding, HEK 293T cells were transfected with
either reporter plasmid IFN-β-Luc (p55C1B-Luc), or NF-κB-Luc and
speciﬁc expression plasmids. Jurkat T-cells were transfected with
IFN-β-Luc reporter plasmid and TBK1-Myc or Tax-1 expression
plasmids as indicated. Empty vector was used to equalize the total
amounts of DNA in all transfections. A plasmid containing the
Renilla gene, under the control of HSV thimidine kinase promoter
(phRG-TK, Promega), was used to normalize the transfection
efﬁciency. Luciferase activity was measured using Dual Luciferase
reporter Assay System (Promega). The transient transfection
assays were performed in triplicate and repeated in at least three
independent experiments. Fold inductions were calculated relative
to promoter alone. Results are presented as mean7standard
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deviation (SD). Signiﬁcant differences are shown as asterisks for p-
valueo0.05.
Semiquantitative RT-PCR analysis
Total RNA was extracted from 293T cells using TRIzol reagent
(Life Technologies) according to manufacturer’s protocol. cDNAs
were generated from total DNase treated RNA, using reverse
transcriptase M-MLV (Life Technologies) and oligo-dT primers.
Semiquantitative RT-PCR was performed with GoTaqs Master
Mix (Promega) and speciﬁc primers for IFN-β and GAPDH tran-
script. The RT-PCR exponential phase was determined at 26 and 32
cycles, for GAPDH and IFN-β expression, respectively, to allow
semiquantitative comparison of cDNAs produced from identical
reactions. The primers and PCR conditions are as previously
described (Cui et al., 2012; Ferronato et al., 2013). The IFN-β
expression analyses were performed in triplicate and repeated in
at least three independent experiments. Quantiﬁcation of the
intensity of the ampliﬁed bands was performed with GelQuant.
NET software provided by http://biochemlabsolutions.com. Fold
inductions were calculated by making reference to the sample
transfected with empty vector. Results are presented as mean
7standard deviation (SD). Signiﬁcant differences are shown as
asterisks for p-valueo0.05.
Results
Tax-1 and Tax-2 interact with IKKε and TBK1
The IKK-related kinases IKKε and TBK1 interact with several
cellular partners and substrates, forming discrete signaling com-
plexes. The speciﬁc function of these complexes is determined by
the scaffold or adaptor proteins recruited in the complexes
(Clément et al., 2008). Since Tax-1 is present in IKK-complexes,
we assessed whether Tax-1 was associated to IKK-related kinases.
We ﬁrst tested (1) whether the increasing amounts of Tax protein
affected the expression level of the IKKɛ and TBK1 kinases and
(2) whether Tax was recruited in the complexes that contain IKKɛ
or TBK1. We performed Western blot analyses of transfected HEK
293T cells, with increasing amounts of vectors expressing Tax-1 in
the presence of equal amounts of vectors expressing either IKKɛ or
TBK1. The results showed that the amount of the IKKɛ and TBK1
kinases was not modiﬁed by the accumulation of Tax-1, compared
to equal amounts of β-tubulin although, in the absence of Tax,
both kinases appear to be less represented in the Western blots
(Fig. 1, panels A and B).
For analysis of the presence of Tax proteins in immunocom-
plexes containing IKKɛ or TBK1, we transfected HEK 293T cells
with constructs expressing Flag-tagged IKKɛ or TBK1, Tax-1 or Tax-
2, followed by immunoprecipitation with an anti-Flag antibody.
Both IKKɛ and TBK1 interacted with Tax-1, as well as with Tax-1
mutant M22, which is defective in the activation of NF-κB path-
way. Interaction with Tax-1 mutant M47, defective in the activa-
tion of CREB pathway (Smith and Greene, 1990) (Fig. 1, panels C
and D), was weak. Tax-2 interaction with IKKε was similar to that
of Tax-1. Since IKKε contains an adaptor region necessary for
binding to adaptor proteins such as the DEAD-box protein 3
(DDX3) (Gu et al., 2013), we investigated whether Tax-1 interac-
tion requires this IKKε binding domain. The immunocomplexes
obtained with the IKKε truncation mutant 1-361, lacking the C-
terminal residues (Breiman et al., 2005), which contains the
adaptor binding region and the scaffold/dimerization domain,
were analyzed. The results indicated that the N-terminal residues
containing the kinase domain (KD) were sufﬁcient to form com-
plexes with Tax-1 (Fig. 2A) and were not overlapping the
previously described IKKε adaptor binding region spanning amino
acids 383 to 647. To verify which Tax-1 domain is sufﬁcient for the
formation of IKKε complexes, we transfected HEK 293T cells with
constructs for Flag-tagged IKKε and V5-tagged Tax-1 truncation
mutants, followed by immunoprecipitation with anti-V5 or anti
Tax-1 antibodies. Results showed that IKKε binds to Tax-1 1-145,
and to Tax-1 61-353 and, at the limit of the detection, to Tax-1
109-353, indicating that Tax-1 N-terminal is sufﬁcient to form
complexes with IKKε (Fig. 2B).
Tax-1 enhances IKKɛ and TBK1 induction of IFN-β promoter
One of the effects of IKKε over-expression in transfected cells is
its auto-activation leading to IRF3 and IRF7 nuclear translocation
and induction of IFN-I promoter (Shimada et al., 1999; Clark et al.,
2009). To investigate the functional relevance of Tax/IKKɛ interac-
tion in the activation of IFN-β promoter, we measured the
expression of luciferase reporter plasmid driven by the IFN-β
promoter in the presence of IKKɛ or TBK1 in HEK 293T transfected
cells. Both IKK-related kinases induced the IFN-β promoter, as
expected, whereas Tax-1 did not (Fig. 3, panels A and B). Expres-
sion of increased amounts of Tax-1 and equal amounts of IKKɛ or
TBK1 led to a synergistic promoter activation. Increases were
similar when both TBK1 and IKKε were expressed in the presence
of Tax-1 (Fig. 3C). When the effect of co-expression of Tax-1 and
IKKɛ was compared with the activation of NF-κB promoter by Tax-
1 alone, no synergistic effect on the induction of NF-κB promoter
was observed (Fig. 3D), indicating that IKKɛ has no effect on Tax
NF-κB activation. Similar results were obtained with Tax-2 in the
activation of both IFN-β and NF-κB promoters (Fig. 3, panels E–G).
The effect of Tax-1 presence in the kinase complexes on IFN-β
induction was conﬁrmed by semiquantitative RT-PCR analysis of
IFN-βmRNA expression (Fig. 3H). 293T cells were transfected with
increased amounts of Tax-1 and equal amount of TBK1. With high
amount of Tax-1 expressing vector, IFN-β expression is signiﬁ-
cantly increased (Fig. 3H). The type I IFN gene activation in the
presence of Tax-1 and TBK1 in T cell like Jurkat cells were also
analyzed. The results obtained showed that IFN-β promoter
activity increased up to three times when Tax-1 was co-expressed,
compared to TBK1 alone (Fig. 3I), similarly to what observed with
293T cells (Fig. 3B).
Tax proteins interact with TRAF3
The data reported above are consistent with a mechanism by
which the Tax proteins interact with IKKɛ and TBK1 complex in a
manner that may lead to IRF3 factor activation. A similar mechan-
ism was demonstrated for the RNA helicase DDX3 to which the
role of a scaffolding adaptor has been attributed. By linking IKKε
and IRF3, DDX3 is capable of coordinating their activation (Gu
et al., 2013). To verify whether Tax proteins may act as adaptors to
other scaffolding proteins participating to the activation of IRF
factors mediated by the IKK-related kinases, we analyzed Tax-1
interaction with IRF3, DDX3 and an upstream factor, TRAF3, which
is involved in both IFN and NF-κB pathways, acting as an E3
ubiquitin ligase (Häcker et al., 2006; Gatot et al., 2007; He et al.,
2007; Kayagaki et al., 2007; Li et al., 2010). There was no
detectable interaction of Tax-1 with either IRF3, or DDX3 (Fig. 4,
panels A and B), whereas co-immunoprecipitation experiments
using Flag-tagged TRAF3 showed a strong interaction with both
Tax-1 and Tax-2 (Fig. 4C). To evaluate the functional effect of Tax-1
interaction with TRAF3, we performed transactivation assays on
both the NF-κB and IFN-β promoters. As previously reported,
TRAF3 activated neither the IFN-β promoter nor the NF-κB
promoter (Parvatiyar et al., 2010; van Zuylen et al., 2012). The
co-expression of TRAF3 with Tax-1 or Tax-2 produced an
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Fig. 1. Tax proteins interact with IKKε and TBK1. HEK 293T cells were co-transfected with empty vector, and with increasing amounts of Tax-1-pJFE and 1 mg of IKKε-Flag or
TBK1-Flag plasmids, as indicated in the panels (A and B). Expression of Tax-1 and IKKε or TBK1 proteins were analyzed by Western blot from transfected cells lysate.
β-tubulin expression was used as a control. The association between Tax proteins with IKK-related kinases were analyzed by immunoprecipitation of protein complexes from
HEK 293T cells co-transfected with vectors expressing Tax-1, Tax-2, Tax-1 mutants M22, M47 with and without IKKε-Flag or TBK1-Flag, as indicated in the panels. Lysates
were immunoprecipitated with anti-Flag antibody and the immunoprecipitates (IP) were analyzed byWestern blot with anti-Tax antibodies. Whole cell extracts (Input) were
analyzed with anti-Tax-1, or anti-Tax-2, and anti-Flag antibodies, as indicated (C and D).
Fig. 2. Functional mapping of Tax-1 and IKKε interacting domains. (A) The functional domains of IKKε constructs are represented by colored boxes: catalytic kinase domain
(KD, in red), the ubiquitin-like domain (ULD, in yellow), the leucine zipper domain (LZ, in green) and the helix-loop-helix domain (HLH, in gray). HEK 293T cells were co-
transfected with Tax-1 and IKKε- or IKKε ΔC-Flag plasmids, as indicated. Lysates were co-immunoprecipitated with anti-Tax-1 antibody and analyzed by Western blot for the
presence of IKKε and IKKε ΔC (IP). Whole cell extracts (Input) were analyzed by Western blot with anti-Tax-1 and anti-Flag antibodies. (B) The functional domains of Tax-1
constructs are represented by colored boxes: the CREB-binding domain (CREB, in orange), the DNA contact domain (in light purple), the leucine zipper region (LZR, in pink),
the NF-κB activating domain (NF-κB, in green), the nuclear export signal (NES, in yellow), the ATF-CREB activating domain (ATF-CREB, in blue) and the PDZ binding domain
(PDZ, in purple). HEK 293T cells were transfected with plasmids encoding V5-tagged Tax-1 full length or truncated mutants (1-145, 61-353 and 109-353) and IKKε as
indicated. Cell extracts were co-immunoprecipitated (IP) with anti-Tax-1 or anti-V5 antibodies and analyzed by Western blot for the presence of IKKε. Whole cell lysates
(Input) were analyzed by Western blot for the presence of Tax-1 and IKKε.
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insigniﬁcant increase in NF-κB promoter activation, as compared
to the Tax activation alone (Fig. 4D). Increased activation of the
IFN-β promoter was observed when Tax-1 was co-expressed with
TRAF3 and IKKε or TBK1 (Fig. 4, panels E and F). No activation was
observed when Tax-1 and TRAF3 were co-expressed. Therefore,
Tax-1 may interact with TRAF3 and increase IFN-β promoter
activity only when IKKɛ and TBK1 are over-expressed.
Discussion
Our data provide structural and functional support for the role
of Tax proteins as adaptor proteins that amplify a receptor-
mediated signal and facilitate coupling of the signal to different
transduction pathways.
In this study, we have shown that Tax-1 expression may
positively regulate IFN-β activation in the presence of the IKK-
related kinases TBK1 and IKKɛ. Our results suggest that Tax is not
involved in the induction of mechanisms that directly circumvent
the IFN response, but it may be recognized by the host system to
induce an IFN antiviral response. It is well known that the Tax
interaction with the host kinases results in the modulation of the
cell signaling response (Xiao et al., 2000, 2001; Sheehy et al.,
2006), but the few experimental studies that have been published
on Tax capacity to interface with IFN-I factors are controversial.
Our data are in accord with results of Suzuki et al. (2010), which
demonstrated that TAK1 activated by Tax-1, induces TBK1-IRF3
activation and the expression of IFN inducible genes, such as
CXCL10 and CCL5. The results of our study provide evidence that
Tax-1 and Tax-2 interact with IKKɛ and TBK1 and that over-
expression of Tax-1 in the presence of TBK1 or IKKɛ induces a
synergistic activation of IFN-β promoter. The reports of others
(Olière et al., 2010; Charoenthongtrakul et al., 2011) point to a
different mechanism. These groups have reported that Tax-1, as
well as HTLV-1 infection, upregulates the expression of the
suppressor of cytokine signaling 1 (SOCS1), which is known to
promote IRF3 degradation. The discrepancy in their results and
ours may be explained by the mechanism that is required for
SOCS1 induction. In their studies, they have shown that Tax
upregulation of SOCS1 required NF-κB. Interestingly, we found
that over-expression of TBK1 or IKKɛ does not impair Tax cap-
ability to activate NF-κB. This was an unexpected result given that
TBK1 and IKKɛ act negatively in NF-κB induction by phosphoryla-
tion of IKKα and IKKβ at sites that suppress their activity (Clark
Fig. 3. Tax proteins increase IKKε and TBK1 activation of IFN-β promoter. HEK 293T cells were transfected with pIFNβ-Luc reporter plasmid (A–C, E, F) or with pNF-κB-Luc
reporter plasmid (D, G), with empty vector or with vectors expressing IKKε-Flag, or TBK1-Myc and increasing amount of Tax-1 or Tax-2 (from 2.5 to 20 ng). On panel F,
trasnfection was performed with 20 ng of Tax-2. The transfection efﬁciency was normalized with equal amount of Renilla luciferase reporter plasmid (phRG-TK). The results
represent the fold increase of luciferase activities calculated with respect to the promoter alone. Semiquantitative RT-PCR. 293T cells were transfected with Tax-1 and TBK1-
Myc expressing plasmids (Panel H), as described in panel B. The total RNA was retrotranscribed and analyzed for IFN-β expression by PCR normalizing the intensity of the
bands to GAPDH expression. Jurkat T cells were transfected with pIFNβ-Luc reporter plasmid and with equal amounts of TBK1-Myc expression plasmid and increasing
amount of Tax-1 (Panel I). Transfection efﬁciency was normalized with equal amount of phRG-TK reporter plasmid The data represent the luciferase fold increase calculated
with respect to TBK1-Myc alone.
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et al., 2011). Our results suggest that Tax induction of NF-κB,
which involves binding of upstream activated kinases such as
MEKK1 and Table2 (Yin et al., 1998; Harhaj and Sun, 1999; Jin et al.,
1999), is not affected by TBK1 and IKKɛ activation. The interaction
of Tax-1 with TBK1 and IKKɛ suggests that these factors exert a
selective role on the activation of the IFN-β pathway. Furthermore,
our results show that Tax proteins interact with TRAF3, a scaffold
protein that is known to act upstream in the IFN pathway but
TRAF3 does not impact on TBK1 and IKKɛ which are autoactivated
in transfected cells (Clark et al., 2009). The previously reported
synergistic effect (Parvatiyar et al., 2010) was obtained with
signiﬁcantly higher amounts of transfected vectors as compared
to our experimental conditions. TRAF3 is a critical antiviral
signaling factor functioning as an E3 ubiquitin ligase and is
essential for the recruitment of IRF3 or IRF7 by TBK1/IKKɛ kinases
allowing efﬁcient phosphorylation of IRF factors (Häcker et al.,
2011). Our results support a model in which Tax-1 may be
recognized by the IKK-related kinase complexes as a scaffold
protein, resulting in the stabilization of the complexes. This
interpretation is in accord with the demonstration that scaffold
proteins over-expressed both in the cells and in complexes
enhance the IRFs phosphorylation mediated by TBK1/IKKɛ, as
reviewed by Chau et al. (2008). In the activating process involving
Tax-1, the selectivity for upstream IFN-I factors is demonstrated by
the Tax-1/TRAF3 interaction and by the absence of Tax-1 in DDX3
and IRF3 complexes. Our data highlight a crucial role of TBK1/IKKɛ
in controlling the interferon-β response in the presence of viral
protein expression. However the exact way by which Tax enhances
TBK1/IKKɛ mediated IFN-β promoter activation needs to be further
investigated.
Conclusions
We have demonstrated that Tax proteins may be recruited in
complexes that contain IKKɛ and TBK1. Tax-1 is not present in
complexes that contain IRF3 or the adaptor protein DDX3, but it
interacts with the TRAF3 upstream cell signaling factor. These
results support a mechanism by which Tax may act as a scaffold
protein between the upstream factors of IFN-β signaling and the
kinase complexes, enabling the interaction between TRAF3 and
TBK1/IKKɛ complex and promoting IRF factors phosphorylation
and IFN-β promoter activation.
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